Andrés C. A. Culasso's research while affiliated with Universidad de Buenos Aires and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (49)
The COVID-19 pandemic has lately been driven by Omicron. This work aimed to study the dynamics of SARS-CoV-2 Omicron lineages during the third and fourth waves of COVID-19 in Argentina. Molecular surveillance was performed on 3431 samples from Argentina, between EW44/2021 and EW31/2022. Sequencing, phylogenetic and phylodynamic analyses were perfor...
Studies about the evolution of SARS-CoV-2 lineages in different backgrounds such as naive populations, are still scarce, especially from South America. The aim of this work was to study the introduction and diversification pattern of SARS-CoV-2 during the first year of the COVID-19 pandemic in the Northwestern Argentina (NWA) region and to analyze...
Objective
In this study, we investigated the occurrence of papillomavirus (PV) infection in non-human primates (NHPs) in northeastern Argentina. We also explored their evolutionary history and evaluated the co-speciation hypothesis in the context of primate evolution.
Methods
We obtained DNA samples from 57 individuals belonging to wild and captiv...
Objective: In this study, we investigated the occurrence of papillomavirus (PV) infection in non-human primates (NHP, Platyrrhine) of northeastern Argentina by using broad-spectrum PCR primers at the L1 gene. In addition, we conducted a phylogenetic and coalescence analysis of viral sequences to explore their evolutionary history and evaluate the c...
Background:
Few studies about the evolutionary history of the hepatitis E virus (HEV) have been conducted. The aim of our work was to investigate and make inferences about the origin and routes of dispersion of HEV-3 in Argentina.
Methods:
Phylogenetic, coalescent and phylogeographic analyses were performed using a 322-bp ORF2 genomic fragment o...
Human adenoviruses (HAdV) are one of the most frequent causes of respiratory infections around the world, causing mild to severe disease. In Argentina, many studies focused on the association of HAdV respiratory infection with severe disease and fatal outcomes leading to the discovery in 1984 of a genomic variant 7h associated with high fatality. A...
HIV-1 is characterized by its ability to mutate and recombine even at polymerase (pol) gene. However, pol-gene diversity is limited due to functional constraints. The aim of this study was to characterize longitudinally, by next-generation sequencing (NGS), HIV-1 variants based on pol-gene sequences, at intra- and inter-host level, from acute/early...
Human immunodeficiency virus type 1 (HIV) primary drug resistance mutations (DRMs) influence the long-term therapeutic effects of antiretroviral treatment (ART). Drug-resistance genotyping based on polymerase gene sequences obtained by next-generation sequencing (NGS) was performed using samples from 10 ART-naïve HIV-infected men who have sex with...
The HCV evolutionary dynamics play a key role in the infection onset, maintenance of chronicity, pathogenicity, and drug resistance variants fixation, and are thought to be one of the main caveats in the development of an effective vaccine. Previous studies in HCV/HIV co-infected patients suggest that a decline in the immune status is related with...
Incorporation of direct acting antivirals (DAA) in the treatment of Hepatitis C Virus (HCV) significantly increases sustained virologic response rates. However, despite the greater potency offered by these antivirals, drug resistance plays a key role in patients with failure to DAA. Nevertheless, there is no information about the prevalence of resi...
Objective:
To evaluate the use of hepatitis C virus (HCV) NS3 sequencing as alternative to the comercially available Versant HCV 2.0 reverse hybridization line-probe assay (LiPA 2.0) to determine HCV genotype 1 (HCV-1) subtypes.
Patients and methods:
A cohort of 104 patients infected by HCV-1 according to LiPA 2.0 was analyzed in a cross-section...
The aim of the present study was to gather information regarding the molecular epidemiology of Human papillomavirus (HPV) and related risk factors in a group of women with low-and high-grade cervical lesions and cancer from the coastal region of Ecuador. In addition, we studied the evolution of HPV variants from the most prevalent types and provide...
Hepatitis C virus (HCV) has a short replication time, high mutation rates and large population sizes, all of which make it an excellent experimental model for evolution studies, because evolution can be visualized in real-time. In this review, we discuss the implications to study HCV evolution at the interpatient and intrapatient levels of infectio...
The aim of this study was to analyze the prevalence of hepatitis C virus (HCV) genotypes in Córdoba province, Argentina, over a 12-year period and to study the changes at the molecular level. The HCV genotype was determined in 357 HCV-infected patients, and the phylogeny and demographic reconstruction for HCV-1 was assessed. A significant reduction...
Human papillomavirus type 16 (HPV16) plays a central role in the development of cervical cancer. Worldwide studies indicate the existence of HPV16 variants that show different geographic distributions and oncogenic potential.
Our goal was to describe the genetic variation of HPV16 isolates identified in urban women with different grades of cervical...
Peripheral blood mononuclear cells (PBMC) from chronic hepatitis C virus-infected persons can harbour viral variants that are not detected in plasma samples. We explored the presence and persistence of HCV genotypes in plasma and PBMC cultures from 25 HCV-monoinfected and 25 HIV/HCV-coinfected patients with haemophilia. Cell cultures were performed...
Human rhinoviruses (HRV) are recognized as a cause of upper and lower acute respiratory infections (ARI). The circulating species and their clinical impact were not described in Argentina.Objectives
To describe the molecular epidemiology of HRV in children and to determine the association of HRV species with outcome and severity.Study design: Hospi...
La riqueza bacteriana de la Antártida marítima ha sido pobremente descripta hasta la actualidad. En este trabajo se estudió la filogenia de un grupo de colecciones bacterianas planctónicas obtenidas de agua de mar de tres localizaciones cercanas a la base científica argentina antártica Jubany (actualmente Carlini). Sesenta secuencias clonadas del A...
Background:
Even though hepatocytes are the main site for hepatitis C virus (HCV) replication, peripheral blood mononuclear cells (PBMC) have also been proposed as a suitable site for HCV replication. However, this issue still remains under discussion. We have previously developed an innovative system where HCV-RNA can be recovered during PBMC cul...
The recent history of the Hepatitis C Virus (HCV) subtypes 1a and 1b in the central region of Argentina is hypothesized by phylogeographic reconstruction using coalescent based Bayesian analyses. Direct partial E2 sequences from HCV 1a and 1b infected patients attending different health-care centers of the country were analyzed.
The inferred date o...
The intra-host evolutionary process of hepatitis C virus (HCV) was analyzed by phylogenetic and coalescent methodologies in a patient co-infected with HCV-1a, HCV-2a, HCV-3a and human immunodeficiency virus (HIV) along a 13-year period.
Direct sequence analysis of the E2 and NS5A regions showed diverse evolutionary dynamics, in agreement with diffe...
The estimated prevalence of HCV infection in Argentina is around 2%. However, higher rates of infection have been described in population studies of small urban and rural communities. The aim of this work was to compare the origin and diversification of HCV-1b in samples from two different epidemiological scenarios: Buenos Aires, a large cosmopolit...
List of available information for the patients analyzed. Sample Code: name of the sample as is shown in the trees. Sample Date: year (B.C.) of the sampling. Gender: M for male, F for female or N/A for not informed/available. Age: Age of the patient at the sampling time. HIV serology: serologic status of the patient for HIV diagnosis (N/A not availa...
THE GLOBAL EPIDEMIOLOGY OF HEPATITIS C VIRUS (HCV) MAY BE ROUGHLY DESCRIBED BY TWO GROUPS OF GENOTYPES: the worldwide distributed ones (subtypes 1a, 1b, 2a and 3a, among others) and the endemic ones (subtypes 4a, 5a, 6a, among others). Epidemiological and population dynamic studies of the worldwide distributed genotypes have shown that subtypes 1a...
A “Sequences”: accession number, name of the sample and sampling year of the external “calibration” dataset. B “BEAST Results”: results of the estimation of the substitution rate with the GenBank sequences. A. Sequences: List of the Genbank's accession number of the sequences used in the external calibration dataset. The Isolation Name and Collecti...
Results of the BaTS analysis using the sample source as trait. Association Index (AI) and Parsimony Score (PS) test the global association between a trait and tree topology, taking into account the level of uncertainty in the phylogenetic reconstruction. The Monophyletic Clade (MC) index tests which traits are associated with phylogeny. The observe...
The history behind the production of clotting factor concentrates produced differences in the prevalence of Hepatitis C Virus (HCV) and other blood-borne infections in haemophilic patients. Prevalence rates of HCV infection up to 100% were reported in patients treated with concentrates before 1985. Conversely, nowadays, viral inactivation and recom...
Raw Results tMRCA Estimations for NS5B region.
(XLS)
Bayesian Skyline Plots for Demographic Reconstruction using E1E2 sequences. X axis: Date in Years A. C.; Y axis: Estimated effective number of infections; Bold Dashed Line: Median time of most recent common ancestor (tMRCA); Light Dashed Line: Upper HPD95% of tMRCA. Bold Line: Mean Effective Number of viral population. Blue Lines: Upper and Lower H...
The Hepatitis C Virus Genotype 2 subtype 2c (HCV-2c) is detected as a low prevalence subtype in many countries, except in Southern Europe and Western Africa. The current epidemiology of HCV in Argentina, a low-prevalence country, shows the expected low prevalence for this subtype. However, this subtype is the most prevalent in the central province...
Maximum likelihood tree for the E2 region constructed using GTR+Γ+I as model of nucleotide substitution with parameters suggested by ModelTest 3.7 (PhyML software). Black bullets: Sequences from the Genotype Reference dataset; Light gray bullets: Sequences from the CdE data set. Dark gray bullets: Sequences from the OLC data set, Numbers above bran...
Neighbor Joining Tree for the NS5B region. The nucleotide substitutions process was modeled with Maximum Composite Likelihood (TrN93) model (MEGA4 software). Black bullets: Sequences from the Genotype Reference dataset; Hollow bullets: Sequences from the HCV-2c dataset. Light gray bullets: Sequences from the CdE data set. Dark gray bullets: Sequenc...
Strict Consensus tree constructed using the 56 most parsimonious trees (2407 steps) found using the New Technology Search (TNT software) for the NS5B region. Black bullets: Sequences from the Genotype Reference dataset; Hollow bullets: Sequences from the HCV-2c dataset. Light gray bullets: Sequences from the CdE dataset. Dark gray bullets: Sequence...
Individuals with haemophilia who received non heat-treated factor concentrates were likely to undergo multiple exposures to the hepatitis C virus (HCV). Therefore, HCV mixed-genotype infections might be more frequent in these patients than in the general population. Their prevalence is extremely variable in similar groups of patients tested by diff...
Citations
... Year Authors Summary points 2023 Torres, et al., [56] The dynamics of the third and fourth waves of variants of the Omicron strain of CVID-19 in ARG are studied, based on phylogenetic and phylodynamic sequencing analyses, concluding that the different propagation dynamics would be due to various factors such as decreased immunity and increased population reinforced with vaccination or immunity to previous strains. 2023 Zhao, et al., [57] This article investigates the relationship between the acceptance of the COVID-19 vaccine by people with chronic diseases and the factors that correlate with their disagreement with vaccination. ...
... PV infection in NWP is scarcer, with reports in asymptomatic captive marmosets, squirrel monkeys, howler monkeys, spider monkeys and titi monkeys (37,47,199). In wildlife PV was detected by PCR in oral swabs of two freeranging NWP, one capuchin and one howler monkey, both from Argentina (176). HPV was investigated by IHC in a case of multicentric cutaneous keratoacanthomas in a freeranging marmoset, but no viral antigen was detected (49). ...
Reference: Infectious diseases of neotropical primates
... In addition, as expected, they exhibited a marked nucleotide divergence with other described HEV-3 subtypes. Altogether, all these findings support previous data that suggested that HEV had a recent introduction in Uruguay and likely from a single geographic origin [42], which is in sharp contrast to other South American countries [43,44] Significant research efforts have been made to obtain additional complete genomes from Uruguay through different enrichment methods, but the low HEV titers in the sample and the lack of an efficient cell culture system have severely hampered the results. ...
... HAdVs are classified into seven species (A-G) as mentioned above. Within each species, HAdV are subclassified into serotypes and/or genotypes [62]. The initial 51 serotypes were determined by neutralization assays or complement fixation assays, while genotypes 52 onwards were described by bioinformatic analysis of whole genome sequences [63,64]. ...
... Given global efforts towards early diagnosis and immediate or rapid ART initiation [50], studies examining in vivo HIV evolution in the absence of ART have become challenging [51][52][53]. ...
... In this study, 29 samples from women with squamous intraepithelial lesions and cervical cancer were studied: 6 ASCUS (Atypical squamous cells of undetermined significance), 3 LSIL (low-grade squamous intraepithelial lesion), 12 HSIL (high-grade squamous intraepithelial lesion) and 7 CC (cervical cancer) attending six community health centers from the Coastal region of Ecuador between 2012-2015 were available for sequencing, including the localities of Esmeraldas (n = 4), Guayas (n = 14), Santa Elena (n = 1), El Oro (n = 1), Los Rios (n = 4), and Manabí (n = 5). All patients had previous results corresponding to HPV16 infection, as described by Bedoya-Pilozo et al., 2018 [20]. This study was approved by the Bioethics Committee (Hospital "Francisco Icaza Bustamente", Ministry of Public Health). ...
... Despite the approval and availability of anti-NS3/4A, anti-NS5A, and anti-NS5B inhibitors for the treatment of HCV infections, naturally occurring polymorphisms (mutations) in target proteins for DAAs have been a major concern [40][41][42]. In recent years, DAAs have enhanced the sustained virologic response (SVR) rate remarkably [43]; however, due to the high replication rate and low fidelity of the HCV-RdRp enzyme, the evolution of the heterogeneous virus populations that are resistant to DAAs remains a major challenge [41]. ...
... However, other regions such as NS3 as an alternative candidate were taken into account by some other groups. As a candidate gene for genotyping purpose, it even showed a comparable sensitivity and specificity level with commercially available Versant HCV 2.0 reverse hybridization lineprobe assay (LiPA 2.0) for subtyping assay (Neukam et al., 2017). In our experiment, it was also revealed that NS3 protease region exhibits a reliable discriminative potential to differentiate between sub-genotype 1a, 1b, and 3a. ...
... [17] As a result, we clarified for the first time that DAA-resistant HCV consisted of resistant virus haplotypes, quasispecies with various HASs, and changed over time during the treatment with different RASs. This indicates that resistance to DAA, [6] growth fitness in the host, [26] and the ability to escape from the immune reaction are different depending on the haplotype [27] and not on the simple individual signature mutations of HCV genomes as previously thought. The HCV haplotype may be involved in a pathological process, such as fibrosis or carcinogenesis, caused by persistent infection of HCV. ...
... There was no association between HBV detection and plasma levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Thus, subjects infected with HBV showed ALT 15 IU l −1 (11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26) and AST 17 IU l −1 (11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23), whereas the corresponding figures among non-HBV infected patients were 15 IU l −1 (11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24) for ALT, and 15 IU l −1 (11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21) and AST 21 IU l −1 (14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32), whereas the levels for non-HCV infected patients were 14 IU l −1 (11)(12)(13)(14)(15)(16)(17)(18)(19)(20) for ALT and 14 IUl −1 (11)(12)(13)(14)(15)(16)(17)(18)(19) for AST (P <0.001 for both ALT and AST). ...